Evidence map›Paper›PMID 33995009›Full record

ArticleFrontiers in pharmacology2021

Biophysical Compatibility of a Heterotrimeric Tyrosinase-TYRP1-TYRP2 Metalloenzyme Complex.

Olga Lavinda, Prashiela Manga, Seth J Orlow, Timothy Cardozo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Phenolic acids inJournal of ginseng research · 2023
    Article
  5. Article
  6. TheGenes · 2022
    Article
  7. Theoretical Studies of Cyanophycin Dipeptides as Inhibitors of Tyrosinases.International journal of molecular sciences · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Olga LavindaDepartment of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, United States.
Prashiela MangaThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, United States.
Seth J OrlowThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, United States.
Timothy CardozoDepartment of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, United States.
New York University · US

Funding

Cutaneous Biology and Skin Disease Training ProgramT32AR064184 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ORLOW, SETH J. · 2014 to 2024
$2.1M
NIAMS NIH HHS T32 AR064184
6 · The paper itself

Abstract

Tyrosinase (TYR) is a copper-containing monooxygenase central to the function of melanocytes. Alterations in its expression or activity contribute to variations in skin, hair and eye color, and underlie a variety of pathogenic pigmentary phenotypes, including several forms of oculocutaneous albinism (OCA). Many of these phenotypes are linked to individual missense mutations causing single nucleotide variants and polymorphisms (SNVs) in

Indexed as

computational molecular dockingmelanosomemolecular modelingoculocutaneous albinismpigmentary disordersprotein-protein interfacetyrosinase

Identifiers

PMID33995009
PMCPMC8114058
OpenAlexW3159686876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.